Clinical Significance of Retinal Emboli During Diagnostic and Therapeutic Cardiac Catheterization

Sponsor
Shiraz University of Medical Sciences (Other)
Overall Status
Completed
CT.gov ID
NCT01157338
Collaborator
(none)
300
1
2
7
43.1

Study Details

Study Description

Brief Summary

Retinal emboli is a common phenomenon in cardiac catheterization. In this study the investigators evaluate the incidence of retinal emboli post diagnostic and therapeutic cardiac catheterization over 300 patients. The incidence was 6.3% and had no clinical sequel on visual acuity and visual field.

Condition or Disease Intervention/Treatment Phase
  • Procedure: diagnostic cardiac catheterization
  • Procedure: therapeutic cardiac catheterization
N/A

Detailed Description

Background and Purpose Cardiac catheterization may cause retinal embolization, a risk factor for cerebrovascular emboli and stroke. We describe the incidence of clinically silent and apparent retinal emboli following diagnostic and interventional coronary catheterization and associated risk factors.

Methods Three hundred selected patients attending a tertiary referral center for diagnostic and therapeutic cardiac catheterization were studied. Direct retinal examination and examination of the visual field and acuity were done before and after catheterization by a retinal specialist.

Study Design

Study Type:
Interventional
Actual Enrollment :
300 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Clinical Significance of Retinal Emboli During Diagnostic and Therapeutic Cardiac Catheterization
Study Start Date :
Oct 1, 2009
Actual Primary Completion Date :
May 1, 2010
Actual Study Completion Date :
May 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: diagnostic cardiac catheterization

patients with diagnostic cardiac catheterization

Procedure: diagnostic cardiac catheterization
coronary intervention: angiography

Active Comparator: therapeutic cardiac catheterization

patient with angioplasty

Procedure: therapeutic cardiac catheterization
cardiac catheterization: angioplasty

Outcome Measures

Primary Outcome Measures

  1. retinal emboli []

    retinal emboli detected by retinal especialist by direct examination

Secondary Outcome Measures

  1. visual field []

    visual field detected by ophthalmologist

  2. visual acuity []

    snellen chart by ophthalmologist

Eligibility Criteria

Criteria

Ages Eligible for Study:
52 Years to 68 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • every patient with diagnostic and therapeutic cardiac catheterization
Exclusion Criteria:
  • patient refusal to follow up ophthalmology

  • abscence of coronary disease in angiogram

  • abnormal retinal angiogram prior to study

Contacts and Locations

Locations

Site City State Country Postal Code
1 shiraz University of medical sciences Shiraz Fars Iran, Islamic Republic of 55318

Sponsors and Collaborators

  • Shiraz University of Medical Sciences

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01157338
Other Study ID Numbers:
  • 1123
First Posted:
Jul 7, 2010
Last Update Posted:
Jul 7, 2010
Last Verified:
Jul 1, 2010
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 7, 2010